Skip to main content
PMC home page
Gut logoLink to Gut
. 1992 Sep;33(9):1260–1263. doi: 10.1136/gut.33.9.1260

Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.

F Cassani 1, L Muratori 1, P Manotti 1, M Lenzi 1, M Fusconi 1, G Ballardini 1, L Selleri 1, U Volta 1, D Zauli 1, R Miniero 1, et al.
PMCID: PMC1379498  PMID: 1330845

Abstract

Antinuclear antibodies with the homogeneous pattern (ANA-H) and smooth muscle antibodies with antiactin specificity (SMA-AA) are regarded as the serum markers of type-1 autoimmune chronic hepatitis. Their diagnostic relevance, however, has been questioned recently after the detection of signs of hepatitis C virus infection in autoimmune chronic hepatitis patients. To further evaluate this point, antihepatitis C virus antibodies were sought by two second generation assays (ELISA 2 and RIBA 2) in 100 Italian patients with chronic liver disease of unknown aetiology, including 46 with (autoimmune chronic hepatitis) and 54 without the above antibodies (cryptogenic). By ELISA 2, antihepatitis C virus, although significantly prevalent in cryptogenic (83%), were found also in a substantial proportion of autoimmune chronic hepatitis patients (46%) (p < 0.0001), their occurrence was confirmed by RIBA 2 in almost all cases (96% and 86%, respectively). Autoimmune patients with either ANA-H or SMA-AA exhibited similar antihepatitis C virus prevalences (59% and 52%, respectively); by contrast, the eight cases positive for both the autoantibodies were consistently antihepatitis C virus negative. These findings confirm that in countries with high hepatitis C virus circulation (like Italy) an overlap between autoimmune chronic hepatitis and hepatitis C virus infection, reflected by 'true' antihepatitis C virus antibodies, does occur. The detection of ANA-H or SMA-AA, in fact, identifies chronic liver disease patients with a relatively low prevalence of antihepatitis C virus, but does not exclude hepatitis C virus infection. Positive findings for both ANA-H and SMA-AA, however, is an appropriate marker for hepatitis C virus free 'primary' autoimmune chronic hepatitis.

Full text

PDF
1260

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bottazzo G. F., Florin-Christensen A., Fairfax A., Swana G., Doniach D., Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol. 1976 May;29(5):403–410. doi: 10.1136/jcp.29.5.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cassani F., Ballardini G., Fusconi M., Lenzi M., Volta U., Zauli D., Bianchi F. B. Anti-HCV antibodies detected by ELISA in autoimmune and cryptogenic chronic liver disease. J Hepatol. 1991 Mar;12(2):269–270. doi: 10.1016/0168-8278(91)90956-c. [DOI] [PubMed] [Google Scholar]
  3. Cassani F., Bianchi F. B., Lenzi M., Volta U., Pisi E. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol. 1985 Jul;38(7):801–805. doi: 10.1136/jcp.38.7.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cassani F., Fusconi M., Bianchi F. B., Selleri L., Baffoni L., Lenzi M., Pisi E. Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies. Clin Exp Immunol. 1987 Jun;68(3):588–595. [PMC free article] [PubMed] [Google Scholar]
  5. Esteban J. I., Esteban R., Viladomiu L., López-Talavera J. C., González A., Hernández J. M., Roget M., Vargas V., Genescà J., Buti M. Hepatitis C virus antibodies among risk groups in Spain. Lancet. 1989 Aug 5;2(8658):294–297. doi: 10.1016/s0140-6736(89)90485-6. [DOI] [PubMed] [Google Scholar]
  6. Fusconi M., Cassani F., Zauli D., Lenzi M., Ballardini G., Volta U., Bianchi F. B. Anti-actin antibodies: a new test for an old problem. J Immunol Methods. 1990 Jun 12;130(1):1–8. doi: 10.1016/0022-1759(90)90291-3. [DOI] [PubMed] [Google Scholar]
  7. Garson J. A., Lenzi M., Ring C., Cassani F., Ballardini G., Briggs M., Tedder R. S., Bianchi F. B. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol. 1991 Aug;34(4):223–226. doi: 10.1002/jmv.1890340405. [DOI] [PubMed] [Google Scholar]
  8. Gurian L. E., Rogoff T. M., Ware A. J., Jordan R. E., Combes B., Gilliam J. N. The immunologic diagnosis of chronic active "autoimmune" hepatitis: distinction from systemic lupus erythematosus. Hepatology. 1985 May-Jun;5(3):397–402. doi: 10.1002/hep.1840050309. [DOI] [PubMed] [Google Scholar]
  9. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  10. Lenzi M., Ballardini G., Fusconi M., Cassani F., Selleri L., Volta U., Zauli D., Bianchi F. B. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet. 1990 Feb 3;335(8684):258–259. doi: 10.1016/0140-6736(90)90070-l. [DOI] [PubMed] [Google Scholar]
  11. Lenzi M., Johnson P. J., McFarlane I. G., Ballardini G., Smith H. M., McFarlane B. M., Bridger C., Vergani D., Bianchi F. B., Williams R. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet. 1991 Aug 3;338(8762):277–280. doi: 10.1016/0140-6736(91)90418-o. [DOI] [PubMed] [Google Scholar]
  12. Mackay I. R., Frazer I. H., Toh B. H., Pedersen J. S., Alter H. J. Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis. Clin Exp Immunol. 1985 Jul;61(1):39–43. [PMC free article] [PubMed] [Google Scholar]
  13. Mackay I. R. Immunological aspects of chronic active hepatitis. Hepatology. 1983 Sep-Oct;3(5):724–728. doi: 10.1002/hep.1840030517. [DOI] [PubMed] [Google Scholar]
  14. Mackay I. R., Whittingham S., Mathews J. D., Tait B. D. Genetic determinants of autoimmune chronic active hepatitis. Springer Semin Immunopathol. 1980 Dec;3(3):285–296. doi: 10.1007/BF02054105. [DOI] [PubMed] [Google Scholar]
  15. Magrin S., Craxì A., Fiorentino G., Fabiano C., Provenzano G., Pinzello G. B., Palazzo U., Almasio P., Pagliaro L. Is autoimmune chronic active hepatitis a HCV-related disease? J Hepatol. 1991 Jul;13(1):56–60. doi: 10.1016/0168-8278(91)90864-8. [DOI] [PubMed] [Google Scholar]
  16. Pedersen J. S., Toh B. H., Mackay I. R., Tait B. D., Gust I. D., Kastelan A., Hadzic N. Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol. 1982 Jun;48(3):527–532. [PMC free article] [PubMed] [Google Scholar]
  17. Sirchia G., Bellobuono A., Giovanetti A., Marconi M. Antibodies to hepatitis C virus in Italian blood donors. Lancet. 1989 Sep 30;2(8666):797–797. doi: 10.1016/s0140-6736(89)90852-0. [DOI] [PubMed] [Google Scholar]
  18. Zauli D., Fusconi M., Crespi C., Bianchi F. B., Craxi A., Pisi E. Close association between basal cell layer antibodies and hepatitis B virus-associated chronic delta infection. Hepatology. 1984 Nov-Dec;4(6):1103–1106. doi: 10.1002/hep.1840040601. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES